• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面分析膀胱癌细胞中 miRNA 基因和免疫检查点基因表达的相关性。

Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

机构信息

SmartImmune Ltd, Accelerate Cambridge, University of Cambridge Judge Business School, Cambridge CB4 1EE, UK.

Laboratory of Molecular Cell Biology, Center for Cancer Research and Department of Medicine C, Sheba Medical Center, Tel Hashome 52621, Israel.

出版信息

Int J Mol Sci. 2021 Mar 4;22(5):2553. doi: 10.3390/ijms22052553.

DOI:10.3390/ijms22052553
PMID:33806327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961343/
Abstract

Personalised medicine is the future and hope for many patients, including those with cancers. Early detection, as well as rapid, well-selected treatment, are key factors leading to a good prognosis. MicroRNA mediated gene regulation is a promising area of development for new diagnostic and therapeutic methods, crucial for better prospects for patients. Bladder cancer is a frequent neoplasm, with high lethality and lacking modern, advanced therapeutic modalities, such as immunotherapy. MicroRNAs are involved in bladder cancer pathogenesis, proliferation, control and response to treatment, which we summarise in this perspective in response to lack of recent review publications in this field. We further performed a correlation-based analysis of microRNA and gene expression data in bladder cancer (BLCA) TCGA dataset. We identified 27 microRNAs hits with opposite expression profiles to genes involved in immune response in bladder cancer, and 24 microRNAs hits with similar expression profiles. We discuss previous studies linking the functions of these microRNAs to bladder cancer and assess if they are good candidates for personalised medicine therapeutics and diagnostics. The discussed functions include regulation of gene expression, interplay with transcription factors, response to treatment, apoptosis, cell proliferation and angiogenesis, initiation and development of cancer, genome instability and tumour-associated inflammatory reaction.

摘要

个性化医学是未来,也是许多患者的希望,包括癌症患者。早期发现以及快速、精选的治疗是导致良好预后的关键因素。microRNA 介导的基因调控是开发新的诊断和治疗方法的有前途的领域,对患者的前景至关重要。膀胱癌是一种常见的肿瘤,死亡率高,缺乏现代先进的治疗方法,如免疫疗法。microRNAs 参与膀胱癌的发病机制、增殖、控制和治疗反应,我们在这篇综述中总结了这方面的内容,以回应该领域最近缺乏综述出版物的情况。我们还对膀胱癌(BLCA)TCGA 数据集的 microRNA 和基因表达数据进行了基于相关性的分析。我们确定了 27 个 microRNA 靶点,它们的表达模式与膀胱癌中免疫反应相关基因的表达模式相反,还有 24 个 microRNA 靶点的表达模式相似。我们讨论了之前将这些 microRNAs 的功能与膀胱癌联系起来的研究,并评估它们是否是个性化医学治疗和诊断的候选者。讨论的功能包括基因表达调控、与转录因子的相互作用、对治疗的反应、细胞凋亡、细胞增殖和血管生成、癌症的发生和发展、基因组不稳定性和肿瘤相关炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/84449caa31a2/ijms-22-02553-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/7c0667853817/ijms-22-02553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/b00ef111b7b4/ijms-22-02553-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/b640e098c885/ijms-22-02553-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/ff45da4493c3/ijms-22-02553-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/3f130025854c/ijms-22-02553-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/314b0f500bdb/ijms-22-02553-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/200ab8d64dad/ijms-22-02553-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/038f5252ceb7/ijms-22-02553-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/84449caa31a2/ijms-22-02553-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/7c0667853817/ijms-22-02553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/b00ef111b7b4/ijms-22-02553-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/b640e098c885/ijms-22-02553-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/ff45da4493c3/ijms-22-02553-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/3f130025854c/ijms-22-02553-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/314b0f500bdb/ijms-22-02553-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/200ab8d64dad/ijms-22-02553-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/038f5252ceb7/ijms-22-02553-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc4/7961343/84449caa31a2/ijms-22-02553-g009.jpg

相似文献

1
Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.全面分析膀胱癌细胞中 miRNA 基因和免疫检查点基因表达的相关性。
Int J Mol Sci. 2021 Mar 4;22(5):2553. doi: 10.3390/ijms22052553.
2
Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.免疫检查点基因特征评估膀胱癌中的免疫浸润特征,并确定 KRT23 为免疫治疗靶点。
BMC Cancer. 2024 Aug 19;24(1):1024. doi: 10.1186/s12885-024-12790-w.
3
The role of microRNAs in bladder cancer.微小 RNA 在膀胱癌中的作用。
Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S60-76. doi: 10.4111/icu.2016.57.S1.S60. Epub 2016 Jun 7.
4
Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes.基于免疫检查点基因的膀胱癌亚型鉴定及预后、免疫特征和免疫治疗预测标志物。
Sci Rep. 2024 Jun 23;14(1):14431. doi: 10.1038/s41598-024-65198-8.
5
Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.吉西他滨耐药膀胱癌细胞中 microRNA-信使 RNA 调控网络的综合分析。
J Cell Biochem. 2019 Apr;120(4):6347-6360. doi: 10.1002/jcb.27922. Epub 2018 Oct 10.
6
Global analysis of miRNA-mRNA regulation pair in bladder cancer.膀胱癌中 miRNA-mRNA 调控对的全局分析。
World J Surg Oncol. 2022 Mar 3;20(1):66. doi: 10.1186/s12957-022-02538-w.
7
Correlating bladder cancer risk genes with their targeting microRNAs using MMiRNA-Tar.使用MMiRNA-Tar将膀胱癌风险基因与其靶向的微小RNA进行关联分析。
Genomics Proteomics Bioinformatics. 2015 Jun;13(3):177-82. doi: 10.1016/j.gpb.2015.05.003. Epub 2015 Jul 10.
8
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.泛癌分析 PARP1 改变作为预测免疫治疗效果的生物标志物及其表达水平与免疫治疗特征的关联。
Front Immunol. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030. eCollection 2021.
9
Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.使用联合 miRNA 和 mRNA 微阵列分析筛选膀胱癌的生物标志物
Mol Med Rep. 2015 Aug;12(2):3170-6. doi: 10.3892/mmr.2015.3739. Epub 2015 May 7.
10
Aberrantly expressed microRNAs in the context of bladder tumorigenesis.膀胱癌发生过程中异常表达的 microRNAs。
Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S52-9. doi: 10.4111/icu.2016.57.S1.S52. Epub 2016 Jun 10.

引用本文的文献

1
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach.肺癌免疫治疗中的耐药性及如何克服它:遗传学视角与联合治疗方法的见解
Cells. 2025 Apr 12;14(8):587. doi: 10.3390/cells14080587.
2
Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects.免疫检查点及其他调节癌症中巨噬细胞的受体-配体对:现状与展望
Cancers (Basel). 2022 Dec 2;14(23):5963. doi: 10.3390/cancers14235963.
3
Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse.

本文引用的文献

1
MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB.微小RNA-223-3p通过靶向RHOB调控非小细胞肺癌细胞的活力、迁移、侵袭及凋亡。
Open Life Sci. 2020 Jun 11;15(1):389-399. doi: 10.1515/biol-2020-0040. eCollection 2020.
2
Cross-platform genomic identification and clinical validation of breast cancer diagnostic biomarkers.跨平台基因组鉴定和乳腺癌诊断生物标志物的临床验证。
Aging (Albany NY). 2021 Jan 20;13(3):4258-4273. doi: 10.18632/aging.202388.
3
hsa-miR-191-5p inhibits replication of human immunodeficiency virus type 1 by downregulating the expression of NUP50.
免疫突触肿瘤侧检查点基因的转录和转录后调控。
Heredity (Edinb). 2022 Jul;129(1):64-74. doi: 10.1038/s41437-022-00533-1. Epub 2022 Apr 22.
hsa-miR-191-5p 通过下调 NUP50 的表达来抑制人类免疫缺陷病毒 1 的复制。
Arch Virol. 2021 Mar;166(3):755-766. doi: 10.1007/s00705-020-04899-7. Epub 2021 Jan 8.
4
lncRNA‑SNHG7‑003 inhibits the proliferation, migration and invasion of vascular smooth muscle cells by targeting the miR‑1306‑5p/SIRT7 signaling pathway.长链非编码 RNA-SNHG7-003 通过靶向 miR-1306-5p/SIRT7 信号通路抑制血管平滑肌细胞的增殖、迁移和侵袭。
Int J Mol Med. 2021 Feb;47(2):741-750. doi: 10.3892/ijmm.2020.4821. Epub 2020 Dec 16.
5
MiR-182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF-κB signaling pathway in endometriosis.miR-182 通过抑制 NF-κB 信号通路的活化抑制子宫内膜异位症中子宫内膜间质细胞的增殖、迁移、侵袭和炎症反应。
Mol Cell Biochem. 2021 Mar;476(3):1575-1588. doi: 10.1007/s11010-020-03986-2. Epub 2021 Jan 5.
6
A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.系统评价 miRNAs 作为胃癌诊断和预后的潜在生物标志物。
Immunogenetics. 2021 Apr;73(2):155-161. doi: 10.1007/s00251-020-01201-6. Epub 2021 Jan 5.
7
MicroRNA-141-3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1.微小 RNA-141-3p 通过靶向结节性硬化复合物 1 调节食管癌中的细胞增殖、迁移和侵袭。
Mol Carcinog. 2021 Feb;60(2):125-137. doi: 10.1002/mc.23274. Epub 2020 Dec 31.
8
Upregulation of miR-1307-3p and its function in the clinical prognosis and progression of gastric cancer.miR-1307-3p的上调及其在胃癌临床预后和进展中的作用。
Oncol Lett. 2021 Feb;21(2):91. doi: 10.3892/ol.2020.12352. Epub 2020 Dec 6.
9
Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.血浆 miR-1247-5p、miR-301b-3p 和 miR-105-5p 作为非小细胞肺癌早期诊断的潜在生物标志物。
Thorac Cancer. 2021 Feb;12(4):539-548. doi: 10.1111/1759-7714.13800. Epub 2020 Dec 28.
10
Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection.循环miR-145-5p/miR-191-5p联合作为乳腺癌检测的生物标志物
PeerJ. 2020 Dec 16;8:e10494. doi: 10.7717/peerj.10494. eCollection 2020.